Can you identify biotech firms with innovative technologies and clinical trial progress?

Biotech firms with innovative technologies and clinical trial progress can be identified by the following criteria: 1. **Revenue Growth**: Companies with a revenue growth rate greater than 10% indicate a strong market demand for their products. 2. **R&D Investment**: A high ratio of R&D expenses to revenue suggests a commitment to innovation and technological advancement. 3. **Clinical Trial Activity**: Companies with a significant number of clinical trials in progress, especially those in Phase 3, indicate a robust pipeline of potential products. 4. **Pipeline Diversity**: A diverse pipeline of drugs or therapies indicates a strong innovation portfolio and reduces dependence on a single product. Here are some biotech firms that meet these criteria: Theme is Biotechnology; Revenue YoY Growth Rate > 10%; R&D Expenses / Revenue > 10%; Number of Clinical Trials in Progress > 3; Clinical Trial Phase = Phase 3 |code|stock code|stock name|Last Price|Last Change|GICS Industry Group|Total Revenue Yoy Growth|Total Revenue|Report End Date|Fiscal Date|Report Period|R&D Expenses|R&D Expenses / Total Revenue|market_code| |---|---|---|---|---|---|---|---|---|---|---|---|---|---| |KROS|KROS.O|Keros|14.48|0.41608900000000004|Pharmaceuticals, Biotechnology & Life Sciences|49002.7027027027|1.8168E7|20250630|20250630|2025Q2|4.3503E7|2.3944848084544255|185| |CYTK|CYTK.O|Cytokinetics|38.67|-0.129132|Pharmaceuticals, Biotechnology & Life Sciences|26714.859437751005|6.6769E7|20250630|20250630|2025Q2|1.12554E8|1.6857224160912998|185| |GERN|GERN.O|Geron|1.45|0|Pharmaceuticals, Biotechnology & Life Sciences|5459.637188208617|4.9036E7|20250630|20250630|2025Q2|2.1736E7|0.4432661717921527|185| |SGMO|SGMO.O|Sangamo Therapeutics|0.58|7.407407000000001|Pharmaceuticals, Biotechnology & Life Sciences|5042.134831460674|1.8306E7|20250630|20250630|2025Q2|2.7084E7|1.4795149131432317|186| |BBIO|BBIO.O|BridgeBio Pharma|51.32|0.273544|Pharmaceuticals, Biotechnology & Life Sciences|4999.861623616236|1.10565E8|20250630|20250630|2025Q2|1.11231E8|1.006023606023606|185| |TRAW|TRAW.O|Traws Pharma|1.51|-6.790123|Pharmaceuticals, Biotechnology & Life Sciences|4694.736842105263|2733000|20250630|20250630|2025Q2|2291000|0.8382729601170874|186| |XAGE|XAGE.O|Longevity Health|2.55|8.510638|Pharmaceuticals, Biotechnology & Life Sciences|3987.7597402597403|503612|20250630|20250630|2025Q2|228606|0.4539327895284465|186| |OVID|OVID.O|Ovid Therapeutics|0.97|15.434964|Pharmaceuticals, Biotechnology & Life Sciences|3611.242603550296|6272000|20250630|20250630|2025Q2|6465000|1.0307716836734695|186| |SPRY|SPRY.O|ARS Pharmaceuticals|14.53|0.414651|Pharmaceuticals, Biotechnology & Life Sciences|3043.4|1.5717E7|20250630|20250630|2025Q2|4035000|0.2567283832792518|185| |IBRX|IBRX.O|ImmunityBio|2.55|-5.904058999999999|Pharmaceuticals, Biotechnology & Life Sciences|2423.8777459407834|2.6425E7|20250630|20250630|2025Q2|5.5236E7|2.0902932828760643|185|